To understand key trends
Download Free Sample
Based on type, the c-arm market size from mobile c-arm segment was valued at more than USD 1.7 billion in 2022. The portable nature of mobile c-arms gives these devices an added advantage over their fixed counterparts, enabling the segment to outperform the other by a significant margin. Mobile c-arm systems are highly manoeuvrable and can be freely oriented around the patient to get ideal angles for high-quality images, whilst also keeping the patient comfortable. Mobile c-arm systems are also constantly evolving through technological advancements, with components such as motorized axes, which facilitate better positioning and movement, becoming an industry mainstay.
With respect to generator power, the c-arm market share from low power segment is anticipated to grow at over 5% CAGR from 2023 to 2032. The lower radiation emissions of low power c-arms machines advocate for their use across healthcare facilities, augmenting the segment revenue. High powered c-arm machines emit harmful radiation that can affect patients, technicians, other healthcare professionals, and the environment, which greatly influences the c-arm purchasing decisions of healthcare organisations by inclining them more towards low power c-arm systems.
In terms of image intensifier, the c-arm market size from 4/6 inch c-arm segment was valued at more than USD 440 million in 2022. The lower prices of mini c-arms, in comparison to the standard-sized machines, are generating a strong demand for 4/6 inch machines, outlining the segment outlook. These machines incorporate a c-arm, console, generator, image intensifier, monitor, and tube inside a single, compact housing. This compact size reduces complexity inside operating theatres and saves precious space in the room. The mini c-arm also emits a lower amount of radiation, making them safer to operate.
To understand key market trends
Download Free Sample
Europe c-arm market size is slated to surpass USD 820 million by 2032, driven by the better accessibility patients have to advanced treatments in the region. High R&D investments and social healthcare policies of European nations makes advanced surgical procedures more cost-effective and readily available for patients, notably favoring market development.
In fact, in March 2022, the UK government unveiled a £260 million (~USD 314 million) scheme to support a new health research initiative, into diagnostics and treatment, led by the NHS. The region’s commitments towards public health and R&D driven advancements in the medical field also makes it a prominent user of health-tech devices such as c-arms, with many industry players putting consistent efforts to secure product approvals through innovation.